ASR Vermogensbeheer N.V. Sells 365 Shares of The Clorox Company $CLX

ASR Vermogensbeheer N.V. trimmed its holdings in shares of The Clorox Company (NYSE:CLX) by 2.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 16,952 shares of the company’s stock after selling 365 shares during the quarter. ASR Vermogensbeheer N.V.’s holdings in Clorox were worth $2,035,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in CLX. Wellington Management Group LLP grew its position in Clorox by 18.8% during the fourth quarter. Wellington Management Group LLP now owns 4,074 shares of the company’s stock valued at $662,000 after buying an additional 646 shares during the period. NBC Securities Inc. grew its position in Clorox by 123,850.0% during the first quarter. NBC Securities Inc. now owns 2,479 shares of the company’s stock valued at $365,000 after buying an additional 2,477 shares during the period. Merit Financial Group LLC grew its position in Clorox by 176.9% during the first quarter. Merit Financial Group LLC now owns 6,297 shares of the company’s stock valued at $927,000 after buying an additional 4,023 shares during the period. RFG Advisory LLC grew its position in Clorox by 13.7% during the first quarter. RFG Advisory LLC now owns 2,406 shares of the company’s stock valued at $354,000 after buying an additional 290 shares during the period. Finally, Hennion & Walsh Asset Management Inc. grew its position in Clorox by 56.2% during the first quarter. Hennion & Walsh Asset Management Inc. now owns 6,828 shares of the company’s stock valued at $1,005,000 after buying an additional 2,456 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

CLX has been the subject of several recent research reports. Zacks Research upgraded shares of Clorox from a “strong sell” rating to a “hold” rating in a research report on Monday, September 29th. Citigroup reiterated a “neutral” rating and issued a $135.00 price target (down from $140.00) on shares of Clorox in a research report on Tuesday, July 15th. Morgan Stanley dropped their price target on shares of Clorox from $150.00 to $137.00 and set an “equal weight” rating for the company in a research report on Friday, August 1st. Wells Fargo & Company dropped their price target on shares of Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a research report on Thursday, September 25th. Finally, The Goldman Sachs Group dropped their price target on shares of Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a research report on Wednesday. One investment analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, Clorox presently has a consensus rating of “Reduce” and an average price target of $134.08.

Clorox Price Performance

CLX stock opened at $123.30 on Friday. The Clorox Company has a one year low of $116.53 and a one year high of $171.37. The company’s fifty day moving average price is $122.81 and its 200-day moving average price is $129.53. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The company has a market capitalization of $15.08 billion, a PE ratio of 18.91, a price-to-earnings-growth ratio of 0.99 and a beta of 0.52.

Clorox (NYSE:CLX) last released its earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The firm had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. During the same quarter in the previous year, the firm earned $1.82 earnings per share. The company’s quarterly revenue was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, equities analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be issued a $1.24 dividend. This represents a $4.96 annualized dividend and a dividend yield of 4.0%. The ex-dividend date of this dividend is Wednesday, October 22nd. Clorox’s payout ratio is 76.07%.

Insider Activity at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.57% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.